Longitudinal study of determinants of medication adherence in COPD
COPD 药物依从性决定因素的纵向研究
基本信息
- 批准号:9306933
- 负责人:
- 金额:$ 68.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAffectAsthmaBehavior TherapyBeliefCause of DeathCharacteristicsChronic DiseaseChronic Obstructive Airway DiseaseClinicalClinical TrialsComorbidityCongestive Heart FailureCross-Sectional StudiesDataDevelopmentDiabetes MellitusDiseaseDisease ProgressionEcological momentary assessmentEvaluationExpectancyFoundationsFrequenciesFutureGoalsHealthHealth Care CostsHealth behaviorHealth systemHigh PrevalenceHospitalsHypertensionImpaired cognitionImpairmentIndividualInformal Social ControlInterventionKnowledgeLinkLongitudinal StudiesLung diseasesMeasuresMediatingMedicalMonitorOutcomeParticipantPatient Self-ReportPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacotherapyPharmacy facilityPopulationPopulation InterventionPublic HealthQuality of lifeReactionRecordsRecruitment ActivityReportingResearchRespiratory Signs and SymptomsRespiratory physiologySamplingSelf EfficacySelf ManagementSymptomsSystemTimeTreatment ProtocolsUnited States Centers for Medicare and Medicaid ServicesVisitbaseburden of illnesscognitive functiondepressive symptomsdisabilityeffective interventionexperiencefunctional statushealth beliefhealth literacyhospital readmissionimprovedinnovationmedication compliancenovelprogramspsychologicpublic health relevancereduce symptomsrespiratorysymptom managementtheoriestherapy development
项目摘要
DESCRIPTION (provided by applicant): COPD is the third leading cause of death and the leading cause of disability in the US. Despite the growing availability of efficacious pharmacotherapy for COPD, patients still experience a significant disease burden and with more than half reporting significant impairment in functioning. Thus the efficacy of COPD medications in clinical trials stands in stark contrast to the poor outcomes experienced by patients in the real world. One possible explanation for this gap is low rates of medication adherence. Only 25% of COPD patients are adherent, which is the lower than other chronic illnesses including diabetes, hypertension and congestive heart failure. Despite the high prevalence of nonadherence in COPD interventions there are significant gaps in the development and evaluation of interventions for adherence. Previous research has been based on cross sectional studies using self-reported measures of adherence and largely a theoretical. In the absence of data, many hospital systems are developing interventions to address medication adherence as part of their clinical program to reduce hospital readmissions and avoid financial penalties from CMS. This project proposes to recruit 360 patients with COPD to longitudinally evaluate potential determinants on adherence and disease progression based on theory of self-regulation. Participants will use novel electronic medication monitors to measure adherence to long term controller and rescue medications and ecological momentary assessments to measure patient reported respiratory symptoms and patients reactions including outcome expectancies, self-efficacy to management symptoms and medication health beliefs. This data will be used to evaluate the theory of self-regulation in COPD. Participants will also complete bi-annual clinical visits to track disease progression on clinical outcomes (e.g., lung function, functional status, quality of life) and psychological/ cognitive functioning. The impact f this study is to identify novel and potentially powerful targets for behavioral interventions in COPD which has been understudied despite its tremendous detrimental impact on overall public health.
描述(由申请人提供):COPD是美国第三大死亡原因和主要残疾原因。尽管COPD的有效药物治疗越来越多,但患者仍然承受着巨大的疾病负担,超过一半的患者报告功能严重受损。因此,COPD药物在临床试验中的疗效与患者在真实的世界中经历的不良结局形成鲜明对比。这种差距的一个可能解释是药物依从性低。只有25%的COPD患者是依从性的,这低于其他慢性疾病,包括糖尿病,高血压和充血性心力衰竭。尽管COPD干预中的不依从性发生率很高,但在依从性干预的开发和评价方面存在显著差距。以前的研究是基于横断面研究,使用自我报告的坚持措施,主要是理论。在缺乏数据的情况下,许多医院系统正在开发干预措施,以解决药物依从性问题,作为其临床计划的一部分,以减少再次入院并避免CMS的经济处罚。本研究拟招募360例COPD患者,以自我调节理论为基础,纵向评估依从性和疾病进展的潜在决定因素。参与者将使用新型电子药物监测器来测量长期控制和急救药物的依从性,并使用生态瞬时评估来测量患者报告的呼吸道症状和患者反应,包括预期结局、对管理症状的自我效能和药物健康信念。这些数据将用于评估COPD的自我调节理论。参与者还将完成一年两次的临床访视,以跟踪临床结局的疾病进展(例如,肺功能、功能状态、生活质量)和心理/认知功能。本研究的影响是确定COPD行为干预的新的和潜在的强有力的目标,尽管其对整体公共卫生的巨大不利影响,但尚未得到充分研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle Nuttall Eakin其他文献
Michelle Nuttall Eakin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle Nuttall Eakin', 18)}}的其他基金
Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)
实施哮喘社区家庭和学校管理计划(哮喘 CHAMPS)
- 批准号:
10206706 - 财政年份:2021
- 资助金额:
$ 68.84万 - 项目类别:
Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)
实施哮喘社区家庭和学校管理计划(哮喘 CHAMPS)
- 批准号:
10474106 - 财政年份:2021
- 资助金额:
$ 68.84万 - 项目类别:
Implementation of a multilevel program to reduce asthma symptoms in urban preschoolers
实施多层次计划以减少城市学龄前儿童的哮喘症状
- 批准号:
10224320 - 财政年份:2020
- 资助金额:
$ 68.84万 - 项目类别:
Implementation of a multilevel program to reduce asthma symptoms in urban preschoolers
实施多层次计划以减少城市学龄前儿童的哮喘症状
- 批准号:
10678876 - 财政年份:2020
- 资助金额:
$ 68.84万 - 项目类别:
Longitudinal study of determinants of medication adherence in COPD
COPD 药物依从性决定因素的纵向研究
- 批准号:
9104979 - 财政年份:2016
- 资助金额:
$ 68.84万 - 项目类别:
Longitudinal study of determinants of medication adherence in COPD
COPD 药物依从性决定因素的纵向研究
- 批准号:
9905415 - 财政年份:2016
- 资助金额:
$ 68.84万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 68.84万 - 项目类别:
Fellowship Programs